| Date | Title | Description |
| 12.01.2022 | Transcarent Raises $200 Million in Series C Funding Highligh... | Led by Kinnevik and Human Capital and joined by Ally Bridge Group, General Catalyst, 7wireVentures a... |
| 09.11.2021 | Arbor Biotechnologies Closes $215 Million Oversubscribed Ser... | The most extensive toolbox of proprietary genomic editors in the industry to enable development of c... |
| 02.11.2021 | Shoreline Biosciences Announces $140M Financing To Advance P... | Financing accelerates the growth of Shoreline’s pipeline of iPSC-based cell immunotherapies for the ... |
| 26.10.2021 | Quantum Surgical Secures 40 Million Euros to Support the Com... | Montpellier, France, October 19th, 2021 – Quantum Surgical, an innovative medical robotic company, a... |
| 08.10.2021 | Morgan Stanley Expansion Capital and Ally Bridge Group Lead ... | Proceeds Used to Acquire ClinEdge and Invest Further in Technology & Data Platform
With access ... |
| 19.08.2021 | Ally Bridge Portfolio News – Illumina Acquires GRAIL to Acce... | GRAIL will remain a separate and independent unit, pending ongoing regulatory and legal review
SAN ... |
| 04.08.2021 | Ally Bridge Portfolio News – Sonoma Biotherapeutics Raises $... | Sonoma Biotherapeutics’ platform and product candidates aim to restore immune system balance through... |
| 16.07.2021 | Ally Bridge Portfolio News – Rapid Micro Biosystems Announce... | July 14, 2021 21:30 ET | Source: Rapid Micro Biosystems, Inc.
LOWELL, Mass., July 14, 2021 (GLOBE N... |
| 16.07.2021 | Ally Bridge Portfolio News – Imperative Care Raises $260 Mil... | Imperative Care to Create Strategic Network of Wholly Owned Development Subsidiaries in Areas of Syn... |
| 28.06.2021 | CMR Surgical raises $600 million in Series D financing, led ... | June 28, 2021 07:00 ET | Source: CMR Surgical
CAMBRIDGE, UK – 28 June 2021, 07:01 (BST). CMR Surgic... |
| 05.06.2021 | Ally Bridge Portfolio News – GRAIL Presents Interventional P... | — Galleri’s ability to detect more than 50 types of cancer with a single blood draw could transform ... |
| 06.05.2021 | Ally Bridge Portfolio News – Vida Health raises $110M in Ser... | New capital to help Vida continue to scale virtual chronic mental and physical healthcare services a... |
| 28.04.2021 | Ally Bridge Portfolio News – Ultivue Announces $50M Financin... | April 27, 2021 10:07 AM Eastern Daylight Time
CAMBRIDGE, Mass.–(BUSINESS WIRE) –Ultivue, a leader i... |
| 16.03.2021 | Ally Bridge Portfolio News – Rapid Micro Biosystems Raises $... | LOWELL, Mass., March 16, 2021 (GLOBE NEWSWIRE) — Rapid Micro Biosystems, Inc., the leading provider ... |
| 03.03.2021 | RefleXion Adds Ally Bridge Group to Investor Syndicate | Expands Series D financing by $40M
March 02, 2021 10:00 AM Eastern Standard Time
HAYWARD, Calif.–(... |
| 17.02.2021 | ABG Acquisition Corp. I Announces Pricing of Upsized $131 Mi... | NEW YORK and HONG KONG, Feb. 16, 2021 /PRNewswire/ — ABG Acquisition Corp. I (the “Company”) today a... |
| 16.02.2021 | Ally Bridge Group Co-leads Mainstay Medical’s $108 Million E... | Funding to support U.S. commercial launch and global expansion
DUBLIN–(BUSINESS WIRE)–Mainstay Medi... |
| 08.02.2021 | Ally Bridge Portfolio News – Next-Gen Proteomics Company Nau... | Nautilus Biotechnology has entered into a definitive merger agreement with Arya Sciences Acquisition... |
| 03.02.2021 | Syapse Announces $68 Million Strategic Investment with Ally ... | February 02, 2021 10:00 ET
— Financing to support expanded partnering opportunities with life scien... |
| 18.12.2020 | Ally Bridge Portfolio News – Hua Medicine Successfully Compl... | Hua Medicine (the”Company”, Stock Code: 2552.HK), a leading innovative drug development company focu... |
| 07.12.2020 | Ally Bridge Portfolio News – Syros Acquires Clinical-Stage D... | Oral Arsenic Trioxide has Potential to Reduce Treatment Burden of Standard-of-Care Regimen that Cure... |
| 19.11.2020 | MedAvail Completes $84 Million Private Placement Led by Ally... | MISSISSAUGA, Ontario & PHOENIX–(BUSINESS WIRE)–MedAvail Holdings, Inc. (“MedAvail”), a leading t... |
| 18.11.2020 | Ally Bridge Portfolio News – MedAvail and MYOS RENS Technolo... | MedAvail, Inc. Set to Trade on NASDAQ Under Ticker Symbol “MDVL”
MISSISSAUGA, Ontario & CEDAR K... |
| 31.10.2020 | Ally Bridge Portfolio News – Atea Pharmaceuticals Announces ... | BOSTON, Oct. 29, 2020 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clini... |
| 28.10.2020 | Ally Bridge Portfolio News – Nuvation Bio and Panacea Announ... | NEW YORK – – October 21, 2020 – Nuvation Bio, Inc., a biopharmaceutical company focused on revolutio... |
| 28.10.2020 | Ally Bridge Portfolio News – Atea Pharmaceuticals Announces ... | Roche Obtains Exclusive Right to Develop and Distribute AT-527 Outside the United States
BOSTON, Ma... |
| 28.10.2020 | Ally Bridge Portfolio News – miRagen Therapeutics, Inc. Anno... | Acquisition includes clinical stage anti-IGF–1R monoclonal antibody, VRDN-001, intended for the trea... |
| 02.10.2020 | Ally Bridge Portfolio News – Pulmonx shares soar 118% in tra... | (MarketWatch) — Shares of Pulmonx, a maker of treatments for lung diseases including emphysema, rose... |
| 21.09.2020 | Ally Bridge Portfolio News – Illumina to Acquire GRAIL to La... | Accelerates Commercialization and Adoption of Transformative Multi-Cancer Screening Test with Potent... |
| 21.08.2020 | Ally Bridge Portfolio News – Bayer and Hua Medicine announce... | August 17, 2020, Beijing and Shanghai, China
Beijing and Shanghai, China, August 17, 2020 – Bayer a... |
| 21.08.2020 | Ally Bridge Portfolio News – Biotechs Tap Growing U.S. Gover... | Federal funding for dementia and Alzheimer’s studies has surged, as venture funding focuses on other... |
| 30.07.2020 | Ally Bridge Portfolio News – Cerevel Therapeutics and Arya S... | July 30, 2020 07:00 AM Eastern Daylight Time
BOSTON–(BUSINESS WIRE)–Cerevel Therapeutics, Inc. (“Ce... |
| 07.07.2020 | Ally Bridge Portfolio News – Unum Therapeutics Inc. Announce... | CAMBRIDGE, Mass. and PHILADELPHIA, July 6, 2020 /PRNewswire/ — Unum Therapeutics Inc. (“Unum”) (NASD... |
| 02.07.2020 | Ally Bridge Portfolio News – Goldfinch Bio Secures $100 Mill... | Proceeds Support Advancement of Lead Product Candidates GFB-887 and GFB-024 Through Three Clinical P... |
| 20.06.2020 | Ally Bridge Portfolio News – Hua Medicine Successfully Compl... | June 18, 2020, Shanghai, China
Hua Medicine (the “Company”, Stock Code: 2552.HK), a leading innovat... |
| 09.06.2020 | Ally Bridge Portfolio News – World Premiere for Quantum Surg... | Montpellier, France, June 8, 2020 – On June 4, 2020, Professor Boris GUIU and his team at Montpellie... |
| 21.05.2020 | Ally Bridge Group Leads US$150 million Financing for Three U... | “The COVID-19 pandemic is undoubtedly a watershed event for life science and healthcare around the g... |
| 21.05.2020 | Ally Bridge Portfolio News – Rapid Micro Biosystems Raises $... | LOWELL, Mass.–(BUSINESS WIRE)–Rapid Micro Biosystems, Inc., the leading provider of fully automated,... |
| 21.05.2020 | Ally Bridge Portfolio News – Atea Pharmaceuticals Announces ... |
BOSTON, May 20, 2020 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc., a biopharmaceutical company en... |
| 09.05.2020 | Ally Bridge Portfolio News – GRAIL Announces $390 Million Se... | MENLO PARK, Calif. — (BUSINESS WIRE) — GRAIL, Inc., a healthcare company whose mission is to detect ... |
| 06.05.2020 | Ally Bridge Group Leads Pulmonx’s $66mn Financing to Support... | REDWOOD CITY, Calif.–(BUSINESS WIRE)–Pulmonx Corporation, a commercial-stage medical technology comp... |
| 01.05.2020 | Ally Bridge Group Leads Vida Health’s $25mn Financing to Sca... | San Francisco, April 30, 2020 — Virtual healthcare platform, Vida Health, announced today that it ra... |
| 16.03.2020 | Ally Bridge Portfolio News – WuXi Biologics and Vir Biotechn... | SAN FRANCISCO and SHANGHAI, Feb. 25, 2020 /PRNewswire/ — WuXi Biologics (“WuXi Bio”) (2269.HK), a le... |
| 21.02.2020 | Ally Bridge Group leads $30 mln investment in Israel’s Mavri... | JERUSALEM, Feb 18 (Reuters) – Israel’s Mavrik Dental Systems has raised $30 million in a funding rou... |
| 19.02.2020 | Ally Bridge Group Leads US$70 million Investments in Two Isr... | TEL AVIV, Israel, HONG KONG and NEW YORK, Feb. 18, 2020 /PRNewswire/ — Ally Bridge Group (“ABG”), a ... |
| 16.12.2019 | Ally Bridge Group Leads More Than US$140 million in Financin... | HONG KONG and NEW YORK, Dec. 16, 2019 /PRNewswire/ — Ally Bridge Group (“ABG”), a leading global lif... |
| 11.12.2019 | Ally Bridge Group Co-leads Imperative Care’s $85 Million Ser... | CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced that it has completed the ini... |
| 04.12.2019 | Ally Bridge Group Leads Venclose’s $27 Million Series C Fund... | SAN JOSE, Calif., Dec. 3, 2019 /PRNewswire/ — Venclose, Inc., a privately-held Silicon Valley medica... |
| 10.05.2019 | Ally Bridge Group Leads Pulmonx’s $65 Million Financing, Fur... | HONG KONG, May 9, 2019 /PRNewswire/ — Ally Bridge Group (“ABG”), a leading global life science inves... |
| 10.05.2019 | Ally Bridge Portfolio News – Pulmonx Closes $65 Million Fina... | REDWOOD CITY, Calif.–(BUSINESS WIRE)–Pulmonx Corporation, a global leader in diagnostic and therapeu... |
| 04.04.2019 | Ally Bridge, LifeTech Scientific and Quantum Surgical Announ... | HONG KONG, SHENZHEN, China, and Montpellier, France, April 4, 2019 /PRNewswire/ — Ally Bridge Group ... |
| 08.03.2019 | Ally Bridge Portfolio News – ShockWave Medical prices upsize... | SANTA CLARA, Calif., March 06, 2019 (GLOBE NEWSWIRE) — ShockWave Medical, Inc. (“ShockWave”) today a... |
| 08.03.2019 | Ally Bridge Portfolio News – ShockWave Medical shares soared... | ShockWave Medical Inc. shares soared by more than 79 percent in its Wall Street debut on Thursday af... |
| 13.12.2018 | Ally Bridge Portfolio News – Wuxi Apptec Successfully Prices... | BioCentury – Dec 8, 2018
Despite global trade headwinds and a choppy market for biopharma stocks in... |
| 13.12.2018 | Ally Bridge Portfolio News – WuXi AppTec Completes Secondary... | HONG KONG and SHANGHAI, December 12, 2018– WuXi AppTec Co., Ltd. (Stock code: 603259.SH/2359.HK) tod... |
| 06.12.2018 | Ally Bridge Portfolio News – TESARO reaches agreement to be ... | LONDON and WALTHAM, Mass., Dec. 03, 2018 (GLOBE NEWSWIRE) — GlaxoSmithKline plc (LSE/NYSE: GSK) and ... |
| 15.11.2018 | Ally Bridge Portfolio News – Vapotherm Shares Soar 14.29% in... | Vapotherm Inc, which provides noninvasive breathing aids to treat respiratory distress, raised $56 m... |
| 01.11.2018 | Ally Bridge Portfolio News – Innovent Biologics hikes on HK ... | October 31, 2018 ENDPOINTS NEWS
Innovent Biologics has surged on its closely watched Hong Kong IPO,... |
| 01.11.2018 | Ally Bridge Portfolio News – Axonics IPO Opened Strong at $1... | October 30, 2018 Business Wire
RVINE, Calif.–(BUSINESS WIRE)–Axonics Modulation Technologies, Inc. ... |
| 19.09.2018 | Ally Bridge Portfolio News – WuXi AppTec Said to File for $1... | September 18, 2018, Bloomberg Report
WuXi AppTec Co., the Chinese contract medical researcher, has ... |
| 19.09.2018 | BioCentury – HUA’S INSTITUTIONAL ADVANTAGE | HUA’S INSTITUTIONAL ADVANTAGE
HOW DIABETES COMPANY HUA NAVIGATED VOLATILE HONG KONG MARKET TO PRICE... |
| 19.09.2018 | Ally Bridge Portfolio News – Hua Medicine Raises $110mn in H... | SEP 14, 2018 | BioCentury
Diabetes company Hua Medicine Ltd. (HKSE:2552) raised HK$867 million ($11... |
| 19.09.2018 | BioCentury – WUXI APPTEC QUEUES UP FOR HONG KONG LISTING | Less than five months after its IPO in Shanghai, WuXi AppTec Co. Ltd. (Shanghai:603259) proposed Tue... |
| 31.07.2018 | Ally Bridge Portfolio News – I-Mab Successfully Raised USD 2... | SHANGHAI, June 29, 2018 /PRNewswire/ — I-Mab Biopharma, a company focusing on innovative Biologics i... |
| 31.07.2018 | Ally Bridge Portfolio News – Chinese sovereign wealth fund b... | Deal Street Asia / Jul 5, 2018
China Investment Corporation (CIC), a sovereign wealth fund has part... |
| 31.07.2018 | BioCentury – Ally Bridge invests in Tasly Biopharmaceuticals... |
Tasly Biopharmaceuticals Co. Ltd. (Shanghai, China) said Wednesday it issued 75.7 million new shar... |
| 31.07.2018 | Ally Bridge Portfolio News – Innovent Announced $150 Million... | ChinaBio Today Report / Apr 29, 2018
Innovent of Suzhou announced its series E financing of $150 mi... |
| 31.07.2018 | Ally Bridge Group News: BioCentury Report – CHINA COMES TO E... |
The historically underfunded European biotech sector is in the early stages of tapping into a new ... |
| 31.07.2018 | Ally Bridge Portfolio News – ABG Among Cornerstone Investors... |
Bloomberg / July 27, 2018, 10:48 PM GMT+8
BeiGene Ltd., a cancer drug developer, is seeking as mu... |
| 12.07.2018 | Ally Bridge Group News: Endpoint News – 12 top China VCs you... |
Money is rushing into biotech at breakneck speed this year, and one part of the globe is accountin... |
| 04.06.2018 | Ally Bridge Portfolio News – Ally Bridge Group Expands Early... | HONG KONG and MONTPELLIER, France, June 3, 2018 /PRNewswire/ — Ally Bridge Group (“ABG”), a leading ... |
| 23.05.2018 | Ally Bridge Portfolio News – GRAIL Announces $300 Million Ra... | MENLO PARK, Calif. & HONG KONG–(BUSINESS WIRE) — GRAIL, Inc., a healthcare company whose mission... |
| 23.05.2018 | Ally Bridge Portfolio News – Ally Bridge Group Leads GRAIL’s... | HONG KONG, May 21, 2018 /PRNewswire/ — Ally Bridge Group, a global life science-focused investment g... |
| 08.05.2018 | Ally Bridge Portfolio News – WUXI APPTEC PRICES A-Share IPO... | Hong Kong and Shanghai, May 8, 2018 / BioCentury / – – Services and manufacturing company WuXi AppTe... |
| 27.03.2018 | Ally Bridge Portfolio News – Hua Medicine Raises $117.4 Mill... | Hua Medicine, a clinical-stage drug development company developing novel therapies for the treatment... |
| 21.03.2018 | Ally Bridge Portfolio News – Boston Scientific Announces Agr... | Acquisition expands portfolio with minimally invasive treatment option for patients with benign pros... |
| 08.01.2018 | Ally Bridge Group and LifeTech Scientific Form China-Global ... | Hong Kong, Shenzhen and San Francisco, January 7, 2018 – Ally Bridge Group (“ABG”), a global healthc... |
| 28.08.2017 | Synlogic Completes Merger with Mirna Therapeutics | CAMBRIDGE, Mass. & AUSTIN, Texas–(BUSINESS WIRE)–Aug. 28, 2017– Synlogic, Inc. and Mirna Therape... |
| 15.06.2017 | PE-backed WuXi Biologics completes Hong Kong re-listing | WuXi Biologics, a Chinese contract R&D services provider to the global pharmaceutical industry t... |
| 25.05.2017 | Ally Bridge reaches ‘inflection point’ with Wuxi IPOs – Prof... | Ally Bridge, the healthcare investment group that whisked Shanghai-based Wuxi Pharmatech from under ... |
| 24.05.2017 | Wuxi Biologics, Wuxi Apptech’s IPOs could benefit from scarc... | The listings of Wuxi Biologics in Hong Kong and the remainder of WuxiPharmatech‘s assets in China wi... |
| 16.03.2017 | Aerpio Pharmaceuticals Raises $40 Million | Aerpio Pharmaceuticals, Inc. (the “Company”), a biopharmaceuticalcompany focused on advancing first-... |
| 21.02.2017 | Ally Bridge Group Expands European Life Science Portfolio wi... | HONG KONG and ZUG, Switzerland, Feb. 21, 2017 /PRNewswire/ — Ally Bridge Group (“ABG”), a leading gl... |
| 15.08.2016 | Serving returns: How Ally Bridge expects to build on top of ... | China’s Ally Bridge Group hit the investment world’s radar in 2015 with its audacious move to take C... |
| 18.07.2016 | Ally Bridge Group Congratulates Medtech SA on its Acquisitio... | HONG KONG, July 18, 2016 /PRNewswire/ — Ally Bridge Group (“ABG”), a leading China-global cross-bord... |
| 03.05.2016 | Building a Global ‘Bridge’ for Life Science Innovation | By Hui Cai, VP of Corporate Alliances at WuXi AppTec (@HuiCai2)
As the globalization of healthcare ... |
| 19.04.2016 | Five Questions For Ally Bridge’s Founder Frank Yu | Frank Yu, founder of healthcare-focused investment firm Ally Bridge Group and formerly head of China... |
| 04.04.2016 | Ally Bridge Group Expands Personalized Medicine Portfolio, I... | HONG KONG, April 4, 2016 /PRNewswire/ — Ally Bridge Group (“ABG”), a leading cross-border healthcare... |
| 23.03.2016 | Ally Bridge keeps cash flowing in $155M private placement in... | Hong Kong-based Ally Bridge Group took a hand in a $155 million placement in immuno-oncology biotech... |
| 21.03.2016 | Ally Bridge Group (ABG) Completes Its Investment in TESARO, ... | HONG KONG, Mar. 21, 2016 /PRNewswire/ — Ally Bridge Group (“ABG”), a global healthcare-focused inves... |
| 10.12.2015 | WuXi PharmaTech (Cayman) Inc. Announces Completion of Going ... | SHANGHAI, Dec. 10, 2015 /PRNewswire/ — WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-acce... |
| 14.08.2015 | Wuxi Pharmatech Enters Into Definitive Merger Agreement | SHANGHAI, Aug. 14, 2015 /PRNewswire/ — WuXi PharmaTech (Cayman) Inc. (“WuXi” or the “Company”) (NYSE... |
| 30.04.2015 | WuXi PharmaTech Announces Receipt of Proposal | SHANGHAI, April 30, 2015 /PRNewswire/ — WuXi PharmaTech (Cayman) Inc. (“WuXi” or the “Company“) (NYS... |